TickerFacts.

Grace Therapeutics, Inc. (GRCE): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-6, first reflected in a filing dated 2023-08-11. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

16.51M
Year ended 2026-03-31
+30.5%
3-year compound annual growth
36.84M2022-03-31: 36.84M2023-03-31: 7.44M2024-03-31: 9.53M2025-03-31: 12.09M2026-03-31: 16.51M16.51M
2022-03-31 Weighted Average Diluted Shares (shares) 2026-03-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2026-03-3116.51M+36.6%2026-06-18, From 2025-04-01
2025-03-3112.09M+26.8%2026-06-18, From 2024-04-01
2024-03-319.53M+28.2%2025-06-23, From 2023-04-01
2023-03-317.44Mn/c2024-06-21, From 2022-04-01
2022-03-3136.84Mn/a2023-06-23, From 2021-04-01